Overview | Agenda | Faculty Materials | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home





Audioconference Agenda

National Pharma Audioconference: Examining the Latest Developments in Drug and Device CIAs How Corporate Integrity Agreements Continue to Reshape Compliance

  • Thursday, August 12, 2010
1:00 pm - 2:30 pm (Eastern)
12:00 pm - 1:30 pm (Central)
11:00 am - 12:30 pm (Mountain)
10:00 am - 11:30 am (Pacific)

The Audioconference agenda is set forth in Eastern Daylight Time below:
(See Faculty Materials page for background reading and information)

1:00 pm Welcome and Introductions
Howard L. Dorfman, Esq.
1:05 pm Discussion of Emerging Risk Areas
Overview of CIAs and the Enforcement Landscape
  • Overview of the current enforcement landscape
  • General overview and update on recent settlements and CIAs
  • The impact of healthcare reform legislation on the industry's compliance obligations related to fraud and abuse
  • Review of other external factors impacting compliance obligations, including requirements promulgated by state legislatures, medical societies, and academic institutions
Howard L. Dorfman, Esq.
1:25 pm Key Elements of Recent CIAs and What They Mean
  • How industry obligations are evolving based on the specific requirements of recent CIAs
Wendy Goldstein, Esq.
1:45 pm An In-house Perspective
  • Analysis of what compliance organizations are required to do based on the specific requirements of a company's CIA
  • How the teachings of the CIAs that follow impact a company's existing compliance obligations
Lawrence Platkin, Esq.
2:05 pm Questions & Answers
2:30 pm Audioconference Adjournment




Overview | Agenda | Faculty Materials | Administration | Contact Us
Privacy Policy | Past Audioconferences | Audioconference Home




© Health Care Conference Administrators
Contact Webmaster